Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
LeMaitre Vascular, Inc. (LMAT) had Cost of Goods Sold of $71.06M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$249.60M |
|
$57.73M |
|
|
Cost of Goods Sold |
$71.06M |
$178.54M |
|
$181.69M |
|
$67.91M |
|
$7.27M |
|
$75.18M |
|
$75.18M |
|
$57.73M |
|
$57.73M |
|
$57.73M |
|
$57.73M |
|
$67.91M |
|
$79.20M |
|
22.64M |
|
22.93M |
|
$2.55 |
|
$2.52 |
|
| Balance Sheet Financials | |
$468.23M |
|
$27.00M |
|
$147.46M |
|
$615.69M |
|
$36.32M |
|
$168.65M |
|
$185.85M |
|
$222.17M |
|
$393.52M |
|
$294.48M |
|
$393.52M |
|
22.77M |
|
| Cash Flow Statement Financials | |
$81.25M |
|
$-64.94M |
|
$-14.54M |
|
$25.61M |
|
$28.24M |
|
$2.63M |
|
$7.83M |
|
$-18.11M |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.89 |
|
-- |
|
-- |
|
0.30 |
|
0.43 |
|
71.53% |
|
27.21% |
|
27.21% |
|
31.73% |
|
30.12% |
|
23.13% |
|
$74.47M |
|
-- |
|
-- |
|
-- |
|
0.41 |
|
1.01 |
|
7.43 |
|
49.15 |
|
14.67% |
|
19.61% |
|
9.38% |
|
10.27% |
|
$17.28 |
|
$3.25 |
|
$3.54 |
|